𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen

✍ Scribed by Robert K. Bright; Michael H. Shearer; Ronald C. Kennedy

Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
610 KB
Volume
40
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunization with soluble simian virus 4
Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4− CD8+ cytotoxic T lymphocytes in mice
✍ Reinhold Schirmbeck; Jens Zerrahn; Andreas Kuhröber; Evelyn Kury; Wolfgang Deppe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 895 KB

## Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4-CD8+ cytotoxic T lymphocytes in mice* C57BL/6 (B6) mice (H-2b) were immunized with the large tumor antigen (T Ag) of simian virus 40 (SV40). Intraperitoneal or subcutaneous sensitization with solub

Differences in the capacity of simian vi
Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice
✍ Lloyd W. Law; Kenneth K. Takemoto; Michael J. Rogers; Ole Henriksen; Robert C. T 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 715 KB

## Abstract The immunogenicity of the SV40 tumor‐specific transplantation antigen (TSTA) on cells, cell particulates and solubilized membranes was studied in mice and in Syrian hamsters. Immunizations were done with various concentrations of tissue‐culture‐passaged, non‐virus‐releasing transformed

Immunization with type 5 adenovirus reco
Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (alvac) cytokine gene delivery induces destruction of established prostate tumors
✍ Bennett D. Elzey; D. Robert Siemens; Timothy L. Ratliff; David M. Lubaroff 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 190 KB

Prostate-specific antigen (PSA) is expressed by prostate epithelial cells and has a highly restricted tissue distribution. Prostatic malignancies in 95% of patients continue to express PSA, making this antigen a good candidate for targeted immunotherapy. The goals of our studies are to generate a re